Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP)
Clinical trial NCT04544995 · TERMINATED
Trial details
- NCT number
- NCT04544995
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-06
- Primary completion
- 2025-04-23
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.